All systems operational
For Researchers For Publishers Login Register
Home Authors Hemant Murthy
HM

Hemant Murthy

h-4 H-Index
33 Citations
6 Papers

Published Papers

6 indexed
1
Lisocabtagene Maraleucel in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2021.09.004
12 citations 392
2
C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucel ☆
Hematology/Oncology and Stem Cell Therapy Q3 2021 10.1016/j.hemonc.2020.09.004
8 citations 389
3
Post-Autologous Hematopoietic Cell Transplant Care in the “Home Sweet Home” Setting: A Treatment Paradigm Shift
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.56875/2589-0646.1088
6 citations 389
4
Understanding the Etiology of Pancytopenias in the CAR T-Cell Therapy Setting
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1047
4 citations 389
5
Emerging Role of Autologous CD19 CAR T-Cell Therapies in the Second-Line Setting for Large B-cell Lymphoma
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1025
3 citations 390
6
Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Hematology/Oncology and Stem Cell Therapy Q3 2025 10.4103/hemoncstem.hemoncstem-d-25-00029
0 citations 392

Publication Activity

Journals Published In

Hematology/Oncology and Stem Cell Therapy
🇸🇦 Q3 AMS 72